Becton, Dickinson uses rating-sensitive bridge for Bard takeover
Becton, Dickinson and Co, the US medical devices group, has obtained a $15.7bn bridge loan for its $24bn buyout of CR Bard, a rival in the same industry. The margin will depend on whether BD can hold on to its credit ratings.
Citiis arranging the facility for the Baa2/BBB+ rated company, but the rating is likely to fall.“Moody’s anticipates that it will downgrade Becton’s senior unsecured rating by two notches to Ba1... if the [Bard] transaction closes,” said Moody’s in a statement on Sunday, when the acquisition ...
Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: firstname.lastname@example.org